KIN Meds review

A broad catalogue still needs a defined task

KIN presents weight care, hormone services, NAD+, sermorelin and a separate laboratory offering. That breadth may simplify looking for a service, but it does not establish that combining them is clinically useful. Decide what question a clinician or test is meant to answer before valuing the rest of the catalogue. ^[1]

NAD+ starts at $249 and sermorelin at $349, with provider visit, supplies and shipping listed included. The public descriptions do not establish the complete concentration, volume, ingredient list or supplied count for each purchase. Both products are expressly unavailable in California. ^{[2] [3]}

Keep the marker and the actual health outcome distinct with the biological-age testing evidence.

Laboratory access is different from included testing

The sermorelin answer describes testing as optional and individualized, with IGF-1 and sometimes thyroid or blood-sugar tests mentioned. The general FAQ sets different laboratory requirements for other care areas. These distinctions should remain attached to the actual prescription, rather than become one monitoring rule for the whole catalogue. ^{[3] [4]}

KIN describes local, at-home and selected-state mobile collection options. Confirm the specific panel, interpretation appointment, collection charge and follow-up. Its separate laboratory service and coming-soon treatment stacks are not evidence that all those items are included with a medication starting price. ^{[1] [3] [4]}

Separate tests, collection and prescriptions in the health-service cost planner.

Requested refills do not settle the initial commitment

Product pages say no auto-subscribe, and the help centre describes asking for a refill before provider review. It says medication is billed at shipment but cancellation closes when processing starts, which it describes as immediate. Agree on the actual supply and charges before submitting the initial request. ^{[2] [3] [4]}

The older refund text instead refers to pre-shipment subscription management and finality after payment and carrier handoff. Ask which agreement applies now. Dispensed medication cannot be returned, and the thirty-day unopened-return provision is for over-the-counter products. The public website terms also leave clinical decisions with independent providers. ^{[5] [6]}

Compare another catalogue and order boundary in our Näky service-and-commitment review.

Compare another clinical-review and purchase arrangement in our Sunlight care-and-order review.

Value the service without inventing a longevity result

Compounded semaglutide and tirzepatide+B12 have separate starting figures of $199 and $249. Branded weight-care consultation starts at $149 per month with the drug separate. These prices cannot be added to an NAD+ headline and treated as a complete preventive-care package. The selected preparation and testing determine the real bill. ^[7]

Compounded drugs are not FDA-approved. Provider messaging, a laboratory measurement or a convenient shipment does not establish more healthy years. I would compare KIN for a defined clinical service and usable follow-up, keeping the usefulness of any test and the evidence for any treatment separate from the healthy-aging theme. ^{[4] [8]}

Compare another provider’s preparation and follow-up scope in the Nova MD service-scope review.

Understanding the cost

NAD+ starts at $249 and sermorelin at $349; compounded semaglutide at $199 and tirzepatide+B12 at $249. Branded consultation separately starts at $149/month without the drug. Confirm selected supply, testing and follow-up costs; no comprehensive all-service package is established.